Company Filing History:
Years Active: 2017-2021
Title: Innovations by Stefanie Krenzlin
Introduction
Stefanie Krenzlin is a notable inventor based in Muenster, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms for treating various diseases. With a total of three patents to her name, her work has the potential to impact the treatment of conditions such as multiple sclerosis and psoriasis.
Latest Patents
Krenzlin's latest patents focus on improved oral dosage forms of methyl hydrogen fumarate and its prodrugs. These innovations not only enhance the delivery of the medication but also provide methods for treating diseases like multiple sclerosis and psoriasis. The advancements in her patents reflect her commitment to improving patient outcomes through effective pharmaceutical solutions.
Career Highlights
Throughout her career, Krenzlin has worked with reputable companies in the pharmaceutical industry, including Arbor Pharmaceuticals and Xenoport. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in drug formulation and delivery.
Collaborations
Krenzlin has collaborated with various professionals in her field, including Sami Karaborni and Sarina Grace Harris Ma. These partnerships have likely enriched her research and development efforts, fostering innovation in her projects.
Conclusion
Stefanie Krenzlin's work exemplifies the impact of innovation in the pharmaceutical industry. Her patents and collaborations highlight her dedication to advancing medical treatments and improving the quality of life for patients.